Antibody-drug Conjugates Market Report 2022: Segment Analysis, Competitive insights, challenges, scope, application and Forecast 2028

Latest research report on “Antibody-drug Conjugates Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.

Get Free Sample Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5613026

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
This report contains market size and forecasts of Antibody-drug Conjugates in global, including the following market information:
Global Antibody-drug Conjugates Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antibody-drug Conjugates Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Antibody-drug Conjugates companies in 2021 (%)
The global Antibody-drug Conjugates market was valued at 2913.3 million in 2021 and is projected to reach US$ 3964 million by 2028, at a CAGR of 4.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adcetris Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antibody-drug Conjugates include ImmunoGen, Seattle Genetics, Roche and Takeda, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibody-drug Conjugates manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Antibody-drug Conjugates Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Antibody-drug Conjugates Market Segment Percentages, by Type, 2021 (%)
– Adcetris
– Kadcyla
Global Antibody-drug Conjugates Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Antibody-drug Conjugates Market Segment Percentages, by Application, 2021 (%)
– Breast Cancer
– Lymphoma
Global Antibody-drug Conjugates Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Antibody-drug Conjugates Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– Europe
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– Asia
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antibody-drug Conjugates revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antibody-drug Conjugates revenues share in global market, 2021 (%)
Key companies Antibody-drug Conjugates sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Antibody-drug Conjugates sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
– ImmunoGen
– Seattle Genetics
– Roche
– Takeda

More information about Discount offers (20% or More)  @ https://www.reportsnreports.com/contacts/discount.aspx?name=5613026

About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.

E-mail: [email protected]

Phone: +1 888 391 5441

Share This Post

Post Comment